Search for: "Kline v. Eli Lilly " Results 1 - 9 of 9
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
26 Mar 2010, 8:21 am by Lawrence B. Ebert
Eli Lilly, a majority of the en banc Federal Circuit decided to retain both traditional and Lilly written description as distinct requirements of patentability. [read post]
9 Nov 2016, 4:53 am by Brian Cordery
The Court reminded itself of the Supreme Court’s treatment of the concept within the context of industrial applicability in HGS v Eli Lilly [2012] where it was held that “even an educated guess” as to the practical application for a claimed product can be sufficient to overcome the plausibility hurdle. [read post]
2 Jun 2011, 12:46 pm by Bexis
Smith, Kline & French Laboratories, 447 So.2d 1301, 1305 (Ala. 1984).AlaskaShanks v. [read post]
15 Jun 2011, 4:56 am by Marie Louise
(Patent Docs) Strattera (Atomoxetine)- US: Patent infringement complaint filed in response to Para IV certification: Eli Lilly & Co. v. [read post]
5 Jul 2007, 10:37 am
Smith, Kline & French Laboratories, 447 So.2d 1301, 1305 (Ala. 1984).Alaska: Shanks v. [read post]